Jennifer Watts, Interim Programme Director for System Support and Evaluation, National Institute for Health and Care Excellence (NICE)
Respiratory disease affects 1 in 5 people and is the third biggest cause of death in England after cancer and cardiovascular disease. It continues to be a major cause of disability and premature mortality.
The report highlights where NICE guidance and standards have contributed to improvements in respiratory care and outcomes for people with lung conditions. We have also developed 6 COVID-19 rapid guidelines related to respiratory conditions to help and support the NHS and social care during the pandemic.
Asthma and chronic obstructive pulmonary disease
The economic impact of asthma and chronic obstructive pulmonary disease (COPD) on the NHS has reached £4.9bn a year. We have published a suite of guidance on asthma and COPD since 2000 and are working with partners to develop UK-wide guidance for the diagnosis and management of chronic asthma. We recently published a COVID-19 rapid guideline on severe asthma and on community-based care of people with COPD, which aim to maximise the safety of those at higher risk, protect staff from infection and enable services to make the best use of resources.